MaryAnn Foote

593 total citations
38 papers, 387 citations indexed

About

MaryAnn Foote is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, MaryAnn Foote has authored 38 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in MaryAnn Foote's work include Health and Medical Research Impacts (6 papers), Neutropenia and Cancer Infections (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). MaryAnn Foote is often cited by papers focused on Health and Medical Research Impacts (6 papers), Neutropenia and Cancer Infections (5 papers) and Biosimilars and Bioanalytical Methods (5 papers). MaryAnn Foote collaborates with scholars based in United States, Germany and Belgium. MaryAnn Foote's co-authors include Graham Molineux, George Morstyn, Miguel H. Bronchud, Olufunmilayo I. Olopade, Giuseppe Giaccone, Theresa Neumann, A Sarah Walker, Ralph Smalling, Steve Elliott and Steven J. Swanson and has published in prestigious journals such as CHEST Journal, The Journal of Infectious Diseases and Stem Cells.

In The Last Decade

MaryAnn Foote

35 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MaryAnn Foote United States 12 104 100 68 59 44 38 387
IsaiahJ. Fidler United States 10 112 1.1× 147 1.5× 132 1.9× 16 0.3× 66 1.5× 11 473
Yuzuru Takemura Japan 13 136 1.3× 210 2.1× 32 0.5× 52 0.9× 117 2.7× 34 475
Kaaron Benson United States 10 55 0.5× 182 1.8× 54 0.8× 166 2.8× 52 1.2× 24 640
David Coniglio United States 13 186 1.8× 47 0.5× 37 0.5× 53 0.9× 62 1.4× 21 344
Clare Lendrem United Kingdom 13 43 0.4× 111 1.1× 88 1.3× 44 0.7× 29 0.7× 29 364
K. Bragman United States 12 131 1.3× 126 1.3× 17 0.3× 32 0.5× 38 0.9× 16 545
Khalid Sait Saudi Arabia 17 151 1.5× 126 1.3× 31 0.5× 18 0.3× 57 1.3× 64 764
John Bainbridge United Kingdom 13 95 0.9× 115 1.1× 26 0.4× 21 0.4× 31 0.7× 23 367
Falk Ehmann Netherlands 14 165 1.6× 132 1.3× 373 5.5× 28 0.5× 64 1.5× 25 859
Sonya Cressman Canada 11 62 0.6× 105 1.1× 12 0.2× 21 0.4× 32 0.7× 28 349

Countries citing papers authored by MaryAnn Foote

Since Specialization
Citations

This map shows the geographic impact of MaryAnn Foote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MaryAnn Foote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MaryAnn Foote more than expected).

Fields of papers citing papers by MaryAnn Foote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MaryAnn Foote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MaryAnn Foote. The network helps show where MaryAnn Foote may publish in the future.

Co-authorship network of co-authors of MaryAnn Foote

This figure shows the co-authorship network connecting the top 25 collaborators of MaryAnn Foote. A scholar is included among the top collaborators of MaryAnn Foote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MaryAnn Foote. MaryAnn Foote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foote, MaryAnn. (2009). How to Write a Better Manuscript. Drug Information Journal. 43(2). 111–114.
2.
Foote, MaryAnn. (2009). The Proof of the Pudding. CHEST Journal. 135(3). 866–868. 13 indexed citations
3.
4.
Foote, MaryAnn. (2007). Why References. CHEST Journal. 132(1). 344–346. 14 indexed citations
5.
Foote, MaryAnn, et al.. (2006). Medical writing departments in biopharma companies: how to establish a department. PubMed. 12. 387–400. 1 indexed citations
6.
Foote, MaryAnn. (2006). Clinical trial registries and clinical trial result posting: new paradigm for medical writers. PubMed. 12. 379–386. 1 indexed citations
7.
Morstyn, George, MaryAnn Foote, & Graham J. Lieschke. (2004). Hematopoietic Growth Factors in Oncology. Humana Press eBooks. 4 indexed citations
8.
Bronchud, Miguel H., MaryAnn Foote, Giuseppe Giaccone, & Olufunmilayo I. Olopade. (2004). Principles of Molecular Oncology. Humana Press eBooks. 39 indexed citations
9.
Foote, MaryAnn. (2004). Guidelines and policies for medical writers in the biotech industry: An update on the controversy. PubMed. 10. 259–264. 1 indexed citations
10.
Smalling, Ralph, MaryAnn Foote, Graham Molineux, Steven J. Swanson, & Steve Elliott. (2004). Drug-induced and antibody-mediated pure red cell aplasia: A review of literature and current knowledge. PubMed. 10. 237–250. 28 indexed citations
11.
Morstyn, George & MaryAnn Foote. (2004). Introduction to hematopoietic growth factors: a general overview. 3–10. 1 indexed citations
12.
13.
Vansteenkiste, Johan, Gregory Rossi, & MaryAnn Foote. (2003). Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia. Expert Opinion on Biological Therapy. 3(3). 501–508. 10 indexed citations
14.
15.
Neumann, Theresa & MaryAnn Foote. (2000). Megakaryocyte growth and development factor (MGDF): An Mpl ligand and cytokine that regulates thrombopoiesis. PubMed. 6(1). 47–56. 18 indexed citations
16.
Foote, MaryAnn & William Welch. (1999). Biopharmaceutical Drug Development: Filgrastim (r-metHuG-CSF) Use in Patients with HIV Infection. Journal of Hematotherapy & Stem Cell Research. 8(supplement 1). 3–8. 2 indexed citations
17.
Welch, William & MaryAnn Foote. (1999). The Use of Filgrastim in AIDS-Related Neutropenia. Journal of Hematotherapy & Stem Cell Research. 8(supplement 1). 9–16. 6 indexed citations
18.
Härtung, Thomas, et al.. (1998). Filgrastim Restores Interleukin‐2 Production in Blood from Patients with Advanced Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 178(3). 686–692. 22 indexed citations
19.
Foote, MaryAnn. (1998). The Importance of Planned Dose of Chemotherapy on Time: Do We Need to Change Our Clinical Practice?. The Oncologist. 3(5). 365–368. 52 indexed citations
20.
Hunt, Pamela S. & MaryAnn Foote. (1995). The new generation of recombinant human hematopoietic cytokines. Current Opinion in Biotechnology. 6(6). 692–697. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by IsaiahJ. Fidler Breakdown of academic impact, for papers by Yuzuru Takemura Breakdown of academic impact, for papers by Kaaron Benson Breakdown of academic impact, for papers by David Coniglio Breakdown of academic impact, for papers by Clare Lendrem Breakdown of academic impact, for papers by K. Bragman Breakdown of academic impact, for papers by Khalid Sait Breakdown of academic impact, for papers by John Bainbridge Breakdown of academic impact, for papers by Falk Ehmann Breakdown of academic impact, for papers by Sonya Cressman
Rankless by CCL
2026